ChemDiv and Jacobs University Announce Strategic Partnership in Drug Discovery
11 Aug 2022
A new dedicated research group will be created on the Jacobs University Bremen campus, merging ChemDiv’s extensive drug discovery expertise and technological platforms with advanced fundamental research conducted at the university. The group will be aimed at design and validation of chemical space, synthesis and identification of active compounds, evaluation of structure-activity relationship, and other crucial elements of drug discovery.
The group will use the existing advanced research infrastructure on campus and will benefit from collaboration with outstanding scientists working at JUB. Strategic goals of the group include: initiation of pioneering projects in drug discovery, acceleration of applied research projects conducted at JUB, creation of spin-off companies, and development of the postgraduate education program which will attract world talents to Bremen.
“Our future Bremen-based research group will complement our emerging focus on strategic collaborations with leading academic partners”, said ChemDiv CEO Ronald Demuth. “It is being supported by the excellent researchers and scientific infrastructure at Jacobs University. Additionally, we will see an innovation boost from the digital knowledge and new technologies provided by Jacobs University. We believe that joining forces with Jacobs University will accelerate our drug discovery projects thus ensuring benefits for the public health,” Demuth explained.
“The agreement with ChemDiv is an excellent example of how fundamental academic research can benefit from industrial expertise, and a focus on new technologies will create added value for the University, companies, researchers, and students of Biology and Chemistry," said Jacobs University President Fabio Pammolli, adding further “ChemDiv and Jacobs University will work together to attract entrepreneurs and start-ups in these areas to settle on campus, creating new career opportunities in the city of Bremen.”
He is looking forward to seeing this corporate collaboration come to fruition, along with further future opportunities for the English-language campus university, which was founded in 2001 and is part of the global ecosystem of the Schaffhausen Institute of Technology (SIT).
ChemDiv Inc. is a recognized global leader in drug discovery solutions. Over the past 32 years, ChemDiv has delivered hundreds of leads, drug candidates and new drugs in the area of CNS, oncology, virology, inflammation, cardiometabolic and immunology, to pharma, biotech and academic partners around the globe.
For more information: https://www.chemdiv.com
About Schaffhausen Institute of Technology (SIT) and Jacobs University Bremen
SIT is a global institution dedicated to promoting Science, Education and Technology. Headquartered in Schaffhausen, Switzerland, SIT is a growing ecosystem comprised of education and research as well as commercial technology spin-offs, consulting services, and investment funds.
Thanks to its two English-language campuses – in Bremen, Germany and in Schaffhausen, Switzerland – SIT offers interdisciplinary university programs to students from around the globe with flexible learning models, both online and on-site. With research and entrepreneurial mentality at its core, the SIT education ecosystem is a gateway to the most in-demand careers in technology and sciences.
Jacobs University Bremen is a university offering a comprehensive range of BSc, MSc, and PhD programs that grant the qualifications required to work in any country in the much-needed careers of our digitalized world. Each student benefits from a well-organized campus life and from synergies with SIT’s research and business ecosystem.
Founded in 2001 as a private, English-language campus university, it repeatedly achieves top results in national and international university rankings. Its more than 1,600 students come from over 110 countries, and around 80 percent have moved to Germany to study. Research projects at Jacobs University are funded by the German Research Foundation or the European Union's Framework Program for Research and Innovation, as well as by globally leading companies.
For more information: https://sit.org
Admission events: https://web.sit.org/roadshow